As of Mar 16
| -0.75 / -3.09%|
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a -14.89% decrease from the last price of 23.50.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.